# Johnson & Johnson (JNJ) — Q2-2014 Earnings Results

**Report date:** 2014-07-15 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2014

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.66 | N/A | +7.58% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report shows that Johnson & Johnson performed better than expected in terms of EPS, indicating strong profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some confidence in the company's financial health.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2014_